Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank40
3Y CAGR-10.2%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-10.2%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20252.38+14.0%
20242.09-23.8%
20232.75-16.7%
20223.30+36.8%
20212.41-
20200.00-